Clozapine: Current perspective
- PMID: 20680140
- PMCID: PMC2910351
- DOI: 10.4103/0019-5545.37668
Clozapine: Current perspective
Abstract
The author conducted a review of studies that compared the efficacy, tolerability and indication for the use of clozapine in current perspectives for the treatment of resistant schizophrenia/ partial responders.
Keywords: Clozapine; SGA; resistant schizophrenia.
Conflict of interest statement
References
-
- Hippius H. The founding of the CINP and the discovery of clozapine. In: Healy D, editor. The psychopharmacologists. New York, NY: Chapman and Hall; 1996. pp. 185–213.
-
- Shen WW. Pharmacotherapy of schizophrenia: The American current status. Keio J Med. 1994;43:192–200. - PubMed
-
- Hippius H. The history of clozapine. Psychopharmacology. 1989;99:S3–5. - PubMed
-
- Gross H, Langner E. Effect profile of a chemically new broad spectrum neuroleptic of the dibenzo-diazepine group. Wien Med Wochenschr. 1966;116:814–6. - PubMed
-
- Bente D, Engelmeier M-P, Heinrich K, Schmitt W, Hippius H. Clinical studies with a neuroleptically active dibenzothiazepine derivative. Arzneimittelforschung. 1966;16:314–6. - PubMed
